Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma

被引:32
作者
Franchi, Alessandro [1 ]
Fondi, Cristina [1 ]
Paglierani, Milena [1 ]
Pepi, Monica [1 ]
Gallo, Oreste [2 ]
Santucci, Marco [1 ]
机构
[1] Univ Florence, Dept Human Pathol & Oncol, I-50134 Florence, Italy
[2] Univ Florence, Dept Otoneuroophtalmol Surg, I-50134 Florence, Italy
关键词
Adenocarcinoma; Intestinal type; Nose and paranasal sinuses; EGFR; Immunohistochemistry; Fluorescent in situ hybridization; Occupational; REFRACTORY COLORECTAL-CANCER; PHASE-II; EGFR; CETUXIMAB; CHEMOTHERAPY; PREDICTS; PROTEIN;
D O I
10.1016/j.oraloncology.2008.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sinonasal intestinal type adenocarcinoma (ITAC) is a rare subtype of adenocarcinoma strongly associated with professional exposure to wood or leather dusts. It is an aggressive tumor, with an estimated 5-year survival of 40%. Herein, we report a series of 55 cases tested for epidermal growth factor receptor protein expression and epidermal growth factor receptor gene copy gains, through immunohistochemistry and fluorescence in situ hybridization. Eighteen tumors (32.7%) showed EGFR positivity, seven of which exhibited high expression levels of the receptor. The frequency of EGF-R overexpression was significantly higher in tumors from woodworkers (6 of 14, 42.8%) than in tumors from leatherworkers (2 of 21, 9.5%), or arising in subjects with no known occupational history (0 of 8) (P = 0.015, Pearson chi square). No correlation was found with other clinico-pathological parameters, including histologic subtype, stage, overall, and disease free survival. In cases with EGFR overexpression, fluorescent in situ hybridization analysis revealed disomy in three adenocarcinomas, chromosome 7 polysomy in two, and EGFR gene amplification in three. In conclusion, a subset of ITAC, mostly occurring in woodworkers, express high levels of EGFR and this is often associated with either gene amplification or chromosome 7 polysomy. EGFR targeted therapies could therefore be investigated prospectively in this group of tumors. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:835 / 838
页数:4
相关论文
共 19 条
  • [1] HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer
    Arteaga, CL
    Moulder, SL
    Yakes, FM
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 4 - 10
  • [2] Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma
    Buckley, Anne F.
    Burgart, Lawrence J.
    Sahai, Vaibhav
    Kakar, Sanjay
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (02) : 245 - 251
  • [3] EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
    Cappuzzo, F.
    Finocchiaro, G.
    Rossi, E.
    Jaenne, P. A.
    Carnaghi, C.
    Calandri, C.
    Bencardino, K.
    Ligorio, C.
    Ciardiello, F.
    Pressiani, T.
    Destro, A.
    Roncalli, M.
    Crino, L.
    Franklin, W. A.
    Santoro, A.
    Varella-Garcia, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (04) : 717 - 723
  • [4] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    Cunningham, D
    Humblet, Y
    Siena, S
    Khayat, D
    Bleiberg, H
    Santoro, A
    Bets, D
    Mueser, M
    Harstrick, A
    Verslype, C
    Chau, I
    Van Cutsem, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) : 337 - 345
  • [5] Franchi A., 2005, Pathology and genetics of head and neck tumours, P20
  • [6] Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO
  • [7] 2-M
  • [8] PROGNOSTIC MARKERS OF COLORECTAL-CANCER - AN EVALUATION OF DNA CONTENT, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND KI-67
    HEMMING, AW
    DAVIS, NL
    KLUFTINGER, A
    ROBINSON, B
    QUENVILLE, NF
    LISEMAN, B
    LERICHE, J
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1992, 51 (03) : 147 - 152
  • [9] Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib
    Hirsch, F. R.
    Varella-Garcia, M.
    Cappuzzo, F.
    McCoy, J.
    Bemis, L.
    Xavier, A. C.
    Dziadziuszko, R.
    Gumerlock, P.
    Chansky, K.
    West, H.
    Gazdar, A. F.
    Crino, L.
    Gandara, D. R.
    Franklin, W. A.
    Bunn, P. A., Jr.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (04) : 752 - 760
  • [10] Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number
    Italiano, Antoine
    Follana, Philippe
    Caroli, Francois-Xavier
    Badetti, Jean-Luc
    Benchimol, Daniel
    Garnier, Georges
    Gugenheim, Jean
    Haudebourg, Juliette
    Keslair, Frederique
    Lesbats, Gerard
    Lledo, Gerard
    Roussel, Jean-Francois
    Pedeutour, Florence
    Francois, Eric
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (02) : 649 - 654